Anti-SARM1/ MyD88-5/ SAMD2 functional antibody

Anti-SARM1/ MyD88-5/ SAMD2 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to SARM1/SARM1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1396-Ab-1/ GM-Tg-hg-SE1396-Ab-2Anti-Human SARM1 monoclonal antibodyHuman
GM-Tg-rg-SE1396-Ab-1/ GM-Tg-rg-SE1396-Ab-2Anti-Rat SARM1 monoclonal antibodyRat
GM-Tg-mg-SE1396-Ab-1/ GM-Tg-mg-SE1396-Ab-2Anti-Mouse SARM1 monoclonal antibodyMouse
GM-Tg-cynog-SE1396-Ab-1/ GM-Tg-cynog-SE1396-Ab-2Anti-Cynomolgus/ Rhesus macaque SARM1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1396-Ab-1/ GM-Tg-felg-SE1396-Ab-2Anti-Feline SARM1 monoclonal antibodyFeline
GM-Tg-cang-SE1396-Ab-1/ GM-Tg-cang-SE1396-Ab-2Anti-Canine SARM1 monoclonal antibodyCanine
GM-Tg-bovg-SE1396-Ab-1/ GM-Tg-bovg-SE1396-Ab-2Anti-Bovine SARM1 monoclonal antibodyBovine
GM-Tg-equg-SE1396-Ab-1/ GM-Tg-equg-SE1396-Ab-2Anti-Equine SARM1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1396-Ab-1/ GM-Tg-hg-SE1396-Ab-2; GM-Tg-rg-SE1396-Ab-1/ GM-Tg-rg-SE1396-Ab-2;
GM-Tg-mg-SE1396-Ab-1/ GM-Tg-mg-SE1396-Ab-2; GM-Tg-cynog-SE1396-Ab-1/ GM-Tg-cynog-SE1396-Ab-2;
GM-Tg-felg-SE1396-Ab-1/ GM-Tg-felg-SE1396-Ab-2; GM-Tg-cang-SE1396-Ab-1/ GM-Tg-cang-SE1396-Ab-2;
GM-Tg-bovg-SE1396-Ab-1/ GM-Tg-bovg-SE1396-Ab-2; GM-Tg-equg-SE1396-Ab-1/ GM-Tg-equg-SE1396-Ab-2
Products NameAnti-SARM1 monoclonal antibody
Formatmab
Target NameSARM1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SARM1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1396-Ag-1Recombinant multi-species SARM1/ MyD88-5/ SAMD2 protein
    ORF Viral VectorpGMLP004282human SARM1 Lentivirus plasmid
    ORF Viral VectorvGMLP004282human SARM1 Lentivirus particle
    ORF Viral VectorpGMLPm005188mouse Sarm1 Lentivirus plasmid
    ORF Viral VectorvGMLPm005188mouse Sarm1 Lentivirus particle


    Target information

    Target IDGM-SE1396
    Target NameSARM1
    Gene ID23098,237868,287545,715863,491165,101100519,536256,100059075
    Gene Symbol and SynonymsA830091I15Rik,hSARM1,HsTIR,MyD88-5,MyD885,SAMD2,SARM,SARM1
    Uniprot AccessionQ6SZW1,D3ZUM2
    Uniprot Entry NameSARM1_HUMAN,SARM1_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000004139
    Target ClassificationN/A

    The target: SARM1, gene name: SARM1, also named as MyD88-5, SAMD2, SARM. Enables NAD+ nucleotidase, cyclic ADP-ribose generating and identical protein binding activity. Involved in NAD catabolic process; positive regulation of neuron death; and response to axon injury. Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.